
Biocon acquires 70% stake in German firm
Biotechnology firm Biocon on Monday announced the acquisition of a 70 per cent stake in German pharmaceutical company, AxiCorp GmbH, for Euro 30 million (over Rs 173 crore), as part of its plan to become a major player in the insulin segment in Europe.
Friedrichsdorf (near Frankfurt) headquartered AxiCorp, a marketing and distribution company, had a turnover of Euro 75 million in 2007.
Biocon Chairman and Managing Director Kiran Mazumdar-Shaw told a press meet that the privately-held AxiCorp, founded in 2002, is a profitable firm. She, however, did not disclose the bottomline of the German company.
She said AxiCorp, which has launched more than 180 products, would add to the combined bottomline going forward.
"AxiCorp is a key strategic investment for Biocon as it heralds our European foray for biosimilars like Recombinant Human Insulin," Mazumdar-Shaw said, adding that the acquisition would help Biocon build strong marketing and distribution capabilities in Europe.
"Both companies share a common vision of affordable healthcare, which we can deliver through a combination of Biocon's low-cost manufacturing and AxiCorp's low-cost distribution," she said.
Mazumdar-Shaw said Biocon is focused on being a key player in the insulin segment and aiming to become the lowest cost insulin maker in the world market.
Biocon said the acquisition would enable marketing and distribution of a range of pharmaceuticals including generics, biosimilars, biologics and pharmaceutical products in Europe, particularly Germany.

Reliance partners with Google, Facebook for digital payment network bid
- Facebook and Google are already partnered with Reliance and own stakes in Jio Platforms

Texas’s power market is $1.3 billion short after energy crisis

McDonald's to sell part of its artificial intelligence start-up

Mukesh Ambani is again richest Asian as China’s Zhong loses $22 billion

Weekly wrap: After early surge, gold prices fall for last 3 days
- Gold set off to a brighter start at the beginning of the week as the price of the precious metal went up by ₹278 to ₹46,013 per 10 grams on Monday.

RBI in favour of retaining inflation target for 5 years

Telecom sector revenues back at pre-Jio levels

Indian shares crash as panic grips bond, global markets

India out of recession as GDP expands 0.4% in Q3

'Hit by double whammy of low growth, high inflation': Cong on economy's state

India's NSE defends reopening market after exchange's shutdown

Oil slumps with wider markets, denting record start to 2021

Reliance Jio launches new unlimited plans to usher in '2G-mukt Bharat'
- According to the plan, new users will get a JioPhone device, unlimited voice calls and data (2GB high-speed data every month) for two years at ₹1,999.

Fiscal deficit rises to ₹12.34 lakh crore at end of January

London could lose out to New York under draft EU finance deal
- Britain's financial services industry has been largely cut off from the EU, its biggest customer, since a Brexit transition period ended on Dec. 31 as the sector is not covered by the UK-EU trade deal.